![Frontiers | Early Cumulative Fluid Balance and Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients With Acute Respiratory Failure: A Multicenter Study | Oncology Frontiers | Early Cumulative Fluid Balance and Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients With Acute Respiratory Failure: A Multicenter Study | Oncology](https://www.frontiersin.org/files/Articles/705602/fonc-11-705602-HTML/image_m/fonc-11-705602-g001.jpg)
Frontiers | Early Cumulative Fluid Balance and Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients With Acute Respiratory Failure: A Multicenter Study | Oncology
![Podcast Episode 50: Simple Sepsis Recognition and Intervention for Prolonged Field Care – ProlongedFieldCare.org Podcast Episode 50: Simple Sepsis Recognition and Intervention for Prolonged Field Care – ProlongedFieldCare.org](https://i0.wp.com/prolongedfieldcare.org/wp-content/uploads/2019/05/WHO-Sepsis-First-2-Hours.png?resize=511%2C600&ssl=1)
Podcast Episode 50: Simple Sepsis Recognition and Intervention for Prolonged Field Care – ProlongedFieldCare.org
![Federal Register :: Medicare Program; CY 2022 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Provider Enrollment Regulation Updates; and Federal Register :: Medicare Program; CY 2022 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Provider Enrollment Regulation Updates; and](https://images.federalregister.gov/ER19NO21.008/original.png?1636726812)
Federal Register :: Medicare Program; CY 2022 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Provider Enrollment Regulation Updates; and
![Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin - ScienceDirect Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952920318796-gr2.jpg)
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin - ScienceDirect
![The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both? - The Journal of Thoracic and Cardiovascular Surgery The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both? - The Journal of Thoracic and Cardiovascular Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2009193236/2031695098/gr3.jpg)
The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both? - The Journal of Thoracic and Cardiovascular Surgery
![Pharmaceuticals | Free Full-Text | Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges | HTML Pharmaceuticals | Free Full-Text | Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00296/article_deploy/html/images/pharmaceuticals-15-00296-g001.png)
Pharmaceuticals | Free Full-Text | Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges | HTML
![Point-of-care testing of plasma free hemoglobin and hematocrit for mechanical circulatory support | Scientific Reports Point-of-care testing of plasma free hemoglobin and hematocrit for mechanical circulatory support | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-83327-5/MediaObjects/41598_2021_83327_Fig1_HTML.png)
Point-of-care testing of plasma free hemoglobin and hematocrit for mechanical circulatory support | Scientific Reports
![Novel application of an automated-machine learning development tool for predicting burn sepsis: proof of concept | Scientific Reports Novel application of an automated-machine learning development tool for predicting burn sepsis: proof of concept | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-69433-w/MediaObjects/41598_2020_69433_Fig2_HTML.png)
Novel application of an automated-machine learning development tool for predicting burn sepsis: proof of concept | Scientific Reports
![Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial - The Lancet Global Health Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial - The Lancet Global Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b4870852-5501-413d-8f2b-c64660998214/gr1_lrg.gif)
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial - The Lancet Global Health
MS18623 Telemetry Transceiver TeleSmart M300 User Manual TSC-f80-en(TUVdraft).book Draeger Medical, .
![Blood Collection from Mice and Hematological Analyses on Mouse Blood - Rathkolb - 2013 - Current Protocols in Mouse Biology - Wiley Online Library Blood Collection from Mice and Hematological Analyses on Mouse Blood - Rathkolb - 2013 - Current Protocols in Mouse Biology - Wiley Online Library](https://currentprotocols.onlinelibrary.wiley.com/cms/asset/05f6e7f2-74ec-4825-b8cf-59dfac6c91cb/cpmo130054-fig-0001-m.jpg)
Blood Collection from Mice and Hematological Analyses on Mouse Blood - Rathkolb - 2013 - Current Protocols in Mouse Biology - Wiley Online Library
![Technology Innovations in Continuous Kidney Replacement Therapy: The Clinician's Perspective - Advances in Chronic Kidney Disease Technology Innovations in Continuous Kidney Replacement Therapy: The Clinician's Perspective - Advances in Chronic Kidney Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dbeb1f44-7498-4a9a-8327-4575e07bc0df/gr1_lrg.jpg)